On Jan 31, 1:58 pm, "3Putt from South Carolina" <3putt@secoastofsc>
wrote:
> Those web pages that I visited looking for an explanation of D90 dosimetry
> was just too technical. The oncologist called yesterday to say my D90 was
> 130, and a very good reading. He suggested it might be too technical for me
> to understand, and would review it with me on my next visit in a couple of
> months. Can anyone provide some insight into this?
Hi 3Putt...As I understand it, D90 is the dose delivered to 90% of the
prostate volume as measured by postimplant dosimetry. So in your case
it sounds like 90% of your prostate received about 130 grays. Some
questions to ask the doc might include..
What dose were you trying to achieve?
Are there any areas in the prostate that received / are receiving a
significantly higher or lower dose?
Did any surrounding areas receive a significantly higher dose that
projected?
Are all the seeds in place and accounted for?
I'm not sure what would be "significant", maybe 25%...Best wishes and
good health, ron
cmdrdata - 01 Feb 2007 12:43 GMT
> On Jan 31, 1:58 pm, "3Putt from South Carolina" <3putt@secoastofsc>
> wrote:
[quoted text clipped - 9 lines]
> it sounds like 90% of your prostate received about 130 grays. Some
> questions to ask the doc might include..
As I am going through RT treatment myself at the moment, the dose
rate, if this
explanation is correct seemed awfully high. My findings on IMRT ranges
from
74-79 Gy (cumulative), and some studies has shown that first
treatement of less
than 73 Gy may not kill all the cancer. High Dose brachytherapy aims
for
40-60 Gy total n 2 fractions.
My SBRT protocol aims for 45 Gy, cumulative, in 5 hypofractions, thus
similar
to HDR Brachy. Can someone more knowledgeable explain?
smithr53 - 01 Feb 2007 18:53 GMT
> > On Jan 31, 1:58 pm, "3Putt from South Carolina" <3putt@secoastofsc>
> > wrote:
[quoted text clipped - 22 lines]
> similar
> to HDR Brachy. Can someone more knowledgeable explain?
IMRT ranges are going to be different than Seed Implant Dose ranges.
Seed Implants allow you to give a larger dose to the Prostate, while
giving a limited dose to the Rectum and Bladder (Critical Structures).
Where as IMRT can Limit dose to critical Structures but only to a
certain degree. The energy of the Photons (Radiation) is different,
for IMRT than it is for seed implants. Seed implants have a lower
energy; therefore the energy is deposited locally. As for the other
HDR procedures you are talking about I would need more information to
elaborate. Also Noted should be that for certain stages of Prostate
cancer certain modalities show a better result.
cmdrdata - 02 Feb 2007 03:33 GMT
> > > On Jan 31, 1:58 pm, "3Putt from South Carolina" <3putt@secoastofsc>
> > > wrote:
[quoted text clipped - 35 lines]
>
> - Show quoted text -
I am well aware of brachytherapy to IMRT/IGRT differences. I also know
the differences between permanent versus HDR where the energy is only
exposed to the prostate for minutes then withdrawn. My question is
about
the "130" Gray. I believe that this is unheard of for brachytherapy.
JohnHace - 02 Feb 2007 04:16 GMT
> My question is about the "130" Gray. I believe that this is unheard of for brachytherapy.
My doctor told me my combined iodine seeds plus EBRT inside the
prostate was over 200 Grays.
John
ron - 02 Feb 2007 15:02 GMT
On Feb 1, 8:33 pm, "cmdrdata" <cmdrd...@mail.com> wrote...snip...
My question is about the "130" Gray. I believe that this is unheard
of for brachytherapy
Looking at some of Radge's and Blasko's papers I see that doses upt to
160 gy are administered with I125 seeds (lower doses with Pd seeds)
depending upon PCa risk classification. When they do SI+XBRT the
combined dose is typically around 200 gy as John H. reports...Best
wishes and good health, ron .
ron - 02 Feb 2007 16:55 GMT
Hi again 3Putt...I was looking at the Zelefsky paper mentioned in
Curtis' post this am. Zelefsky notes, "Among patients where the I-125
dose to 90% of the prostate (D90) was >/=130 Gy, the 8-year PSA
relapse-free survival (PRFS) was 93% compared with 76% for those with
lower D90 dose levels (p < 0.001)"..Best wishes and good health...ron
3Putt from South Carolina - 02 Feb 2007 18:52 GMT
> Hi again 3Putt...I was looking at the Zelefsky paper mentioned in
> Curtis' post this am. Zelefsky notes, "Among patients where the I-125
> dose to 90% of the prostate (D90) was >/=130 Gy, the 8-year PSA
> relapse-free survival (PRFS) was 93% compared with 76% for those with
> lower D90 dose levels (p < 0.001)"..Best wishes and good health...ron
Thanks Ron. I've my first after treatment PSA 1st week of April and visit
with the urologist a few days after. Meanwhile my wife has had an MRI last
week, CT and sonogram today as a 3 month followup to breast cancer
treatments. Some problem areas showed up, but we refuse to dwell on the
issues and get on with our lifes.